Psychopharmacological and analgesic action of selective serotonin reuptake inhibitor antidepressants fluoxetine in female mouse

被引：0
作者：
Cobo-Realpe L. [1 ]
Collazos C.A. [2 ]
Castellanos H.E. [2 ]
Herrera-Mendoza K. [3 ]
机构：
[1] Grupo Biopsiquismo y Sociedad, Universidad Manuela Beltrán, Bogotá D.C
[2] Grupo de Ciencias Básicas y Laboratorios, Universidad Manuela Beltrán, Bogotá D.C.
[3] Grupo de Investigación Cultura, Educación y Sociedad, Programa de psicología, Universidad de la Costa CUC, Barranquilla
来源：
Informacion Tecnologica | 2020年 / 31卷 / 03期
关键词：
Analgesic; Antidepressant; Fluoxetine; Selective serotonin reuptake inhibition;
D O I：
10.4067/S0718-07642020000300039
中图分类号：
学科分类号：
摘要：
The main objective of this paper is to establish the potency range and the action mechanism of selective serotonin reuptake inhibition (SSRI) fluoxetine on female CD-1 mice (25-39 kg). Our results indicated that fluoxetine´s antidepressant doses of 16 mg/kg (i.p.), 32 mg/kg (i.p.), and 64 mg/kg (i.p.) had an analgesic and anxiolytic effect without significant results on the spatial memory test. Reduced activity on memory work on specific activities was only observed with a dose of 64 mg/kg (i.p.). This is evidence to suggest that fluoxetine can be more effective with doses that showed an antidepressant effect. It also indicates that fluoxetine can have an analgesic and anxiolytic effect without reducing motor activity on mice. The maximum dose tested on this study showed variations on motor activity of mice suggesting that SSRI fluoxetine can have sedative effects. © 2020 Centro de Informacion Tecnologica. All rights reserved.
引用
收藏
页码：39 / 50
页数：11
相关论文
共 29 条
  • [21] Oliver B., Serotonin: A Never-Ending Story, European Journal of Pharmacology, 753, pp. 2-18, (2015)
  • [22] Olton D. S., The Radial Arm Maze as a Tool in Behavioral Pharmacology, Physiology & Behavior, 40, 6, pp. 793-797, (1987)
  • [23] Ramamoorthy S., Regulation of Monoamine Transporters: Role of Transporter Phosphorylation, Pharmacol and Therapeutics, 129, 2, pp. 220-238, (2011)
  • [24] Schatzberg A. F, Nemeroff C. B., Tratado de Psicofarmacología, pp. 1-226, (2006)
  • [25] Schreiber S., Pick C. G., From Selective to Highly Selective SSRIs: A Comparison of the Antinociceptive Properties of Fluoxetine, Fluvoxamine, Citalopram and Escitalopram, European Neuropsychopharmacology, 16, 6, pp. 464-468, (2006)
  • [26] De Souza J. M., Zinc Oxide Nanoparticles in Predicted Environmentally Relevant Concentrations Leading to Behavioral Impairments in Male Swiss Mice, pp. 653-662, (2018)
  • [27] Sugimoto Y., Effects of the Serotonin and Noradrenaline Reuptake Inhibitor (SNRI) Milnacipran on Marble Burying Behavior in Mice, Pharm. Bull, 30, 12, pp. 2399-2401, (2007)
  • [28] Umathe S. N., Involvement of Endocannabinoids in Antidepressant and Anti-Compulsive Effect of Fluoxetine in Mice, Behavioural Brain Research, 223, 1, pp. 125-134, (2011)
  • [29] Vahid-Ansari F., Abrogated Freud-1/Cc2d1a Repression of 5-HT1A Autoreceptors Induces Fluoxetine-Resistant Anxiety/Depression-Like Behavior, The Journal of Neuroscience, 37, (2017)
123